Search - tctmd.com

Displaying 41 - 60 of 176

Sort: Relevancy | Date

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Conference News EuroPCR 2020

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Michael O'Riordan

June 30, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Daily News

Better Adherence to Guideline Advice Pays Off After Acute MI

Yael L. Maxwell

March 11, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Shelley Wood

January 20, 2020

News Conference News AHA 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Yael L. Maxwell

November 21, 2019

News Conference News AHA 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Yael L. Maxwell

November 17, 2019

News Daily News

Women More Likely Than Men to Develop Heart Failure After STEMI

L.A. McKeown

November 04, 2019

News Daily News

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

L.A. McKeown

November 01, 2019

News Daily News

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

Michael O'Riordan

October 17, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

News Conference News ESC 2019

Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART

Yael L. Maxwell

September 04, 2019

News Conference News ESC 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Yael L. Maxwell

September 01, 2019

News Conference News ESC 2019

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

Michael O'Riordan

August 31, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

Taking Ticagrelor? Frank, Proactive Patient Conversations are Needed to Help With Adherence

News Daily News

Taking Ticagrelor? Frank, Proactive Conversations are Needed to Help With Adherence

Yael L. Maxwell

May 17, 2019

News Daily News

African-American ACS Patients Less Often Treated With Prasugrel After PCI

Yael L. Maxwell

January 24, 2019

Advertisement

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Better Adherence to Guideline Advice Pays Off After Acute MI

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Women More Likely Than Men to Develop Heart Failure After STEMI

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Taking Ticagrelor? Frank, Proactive Conversations are Needed to Help With Adherence

African-American ACS Patients Less Often Treated With Prasugrel After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content